Vyome Holdings, Inc. (formerly ReShape Lifesciences Inc.) is a clinical-stage specialty pharmaceutical company based in Cambridge, MA/Princeton, NJ/New Delhi, India, focused on immune-inflammatory and rare diseases. Its lead program VT-1953 is a topical gel for malignant fungating wounds in advanced cancer. Other programs include VT-1908 ophthalmic drops for anterior uveitis and VB-1953 for moderate-to-severe acne. The company also commercializes antifungal topical products in India via a licensing agreement with Sun Pharma.
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-18 | 2025-12-31 | 0001213900-26-029500 | EDGAR | 115K words |
| 2025-04-04 | 2024-12-31 | 0001558370-25-004477 | EDGAR | 81K words |
| 2024-04-01 | 2023-12-31 | 0001558370-24-004559 | EDGAR | 61K words |
| 2023-04-17 | 2022-12-31 | 0001558370-23-006079 | EDGAR | — |
| 2022-04-08 | 2021-12-31 | 0001558370-22-005238 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001558370-21-002923 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001427570-20-000018 | EDGAR | — |
| 2019-02-22 | 2018-12-31 | 0001427570-19-000019 | EDGAR | — |
| 2018-03-05 | 2017-12-31 | 0001427570-18-000013 | EDGAR | — |
| 2017-02-23 | 2016-12-31 | 0001628280-17-001603 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001213900-26-088402 | EDGAR | 31K words |
| 2025-11-14 | 2025-09-30 | 0001213900-25-110980 | EDGAR | 31K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011594 | EDGAR | 21K words |
| 2025-05-20 | 2025-03-31 | 0001558370-25-008031 | EDGAR | 17K words |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015732 | EDGAR | 19K words |
| 2024-08-14 | 2024-06-30 | 0001558370-24-012246 | EDGAR | 19K words |
| 2024-05-15 | 2024-03-31 | 0001558370-24-008304 | EDGAR | 14K words |
| 2023-11-09 | 2023-09-30 | 0001558370-23-018344 | EDGAR | 19K words |
| 2023-08-07 | 2023-06-30 | 0001558370-23-013645 | EDGAR | 18K words |
| 2023-05-15 | 2023-03-31 | 0001558370-23-009920 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017869 | EDGAR | — |
| 2022-08-19 | 2022-06-30 | 0001558370-22-013821 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-28 | 0001213900-26-095093 | EDGAR | 4K words |
| 2026-08-25 | 0001213900-26-093512 | EDGAR | 2K words |
| 2026-02-25 | 0001213900-26-020387 | EDGAR | 19K words |
| 2026-02-13 | 0001213900-26-015795 | EDGAR | 2K words |
| 2026-01-28 | 0001213900-26-008575 | EDGAR | 5K words |
| 2025-12-23 | 0001213900-25-125310 | EDGAR | 2K words |
| 2025-11-19 | 0001213900-25-112728 | EDGAR | 2K words |
| 2025-10-30 | 0001213900-25-104121 | EDGAR | 1K words |
| 2025-10-03 | 0001213900-25-096156 | EDGAR | 1K words |
| 2025-09-02 | 0001213900-25-082924 | EDGAR | 16K words |
244 total filings indexed. 212 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001427570 |
| Ticker | HIND |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Cambridge, MA / Princeton |
| Website | https://vyometx.com |
| Listed | 2025-08-15 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HIND (~200 tokens, structured JSON with cryptographic provenance)